Pfizer Inc. (NYSE:PFE)reported on Thursday that its third-quarter profit plunged 14% to $3.2 billion, or 43 cents per share, as compared to $3.74 billion, or 48 cents per share, in the last year same quarter.
Revised profit declined to 53 cents per share from 60 cents per share. Sales plunged 16% to just below $14 billion.
Pfizer referred the loss of exclusivity for its cholesterol drug Lipitor as a main cause of its sluggish sales.
Wall Street experts predicted Pfizer to earn 52 cents per share on sales of $14.7 billion, as per reported by a FactSetpoll.
Pfizer hold plans to repurchase almost $10 billion in stock following it ends the sale of its Nutrition business to Nestle in the coming few months.
Its competitors include Sanofi SA (ADR) (NYSE:SNY) that surged +2.46% to $44.93 with the total traded volume of 990,066.00 shares and Merck & Co., Inc. (NYSE:MRK) that surged +1.21% to $46.18 with the total traded volume of 10.67 million shares.
Other Healthcare stocks with bullish trend include Bristol Myers Squibb Co. (NYSE:BMY) up +1.05% to $33.60, Johnson & Johnson (NYSE:JNJ) up 1.27% to $71.72 and Boston Scientific Corporation (NYSE:BSX) up +0.78% to $5.18, whereas with bearish trend include Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) down -1.19% to $7.82, ABIOMED, Inc. (NASDAQ:ABMD) down -29.82% to $13.91 and VIVUS, Inc. (NASDAQ:VVUS) down -1.64% to $14.65.
Pfizer Inc. (NYSE:PFE) dropped -1.37% or -$0.34 to trading at $24.53 following it hit intra day high level of $24.82. The total traded volume in the current trading session is 30.12 million shares as compared to average 26.90 million shares. Its fifty two week trading range is $18.15 – $26.09. The total market capitalization reached $183.23 billion.
The stock price was ahead its 52 week low price with +38.92% and it lagged behind -6.13% from its 52 week maximum mark. Stock price volatility for last month remained 1.38%. In its share capital, the company has 7.47 billion outstanding shares out of which 7.47 billion shares have been floated in the market. For now, stock ownership with company’s management remained 0.02%.
PFE presented a pessimistic weekly performance of -2.85% with respect to its rate of return and it remained +0.08% for the month. However, the performance for a quarter experienced a positive change of +4.41% and it surged +30.55% for a year and its year to date performance remained in red with +18.37%.
Current stock price is in the downbeat territory taking into account of 20 days moving average with -3.67% and continued negatively run for 50 days moving average with -0.77%. Its earning per share for the past twelve months was $1.15. Company’s beta coefficient was at 0.71. Beta measures the amount of market risk associated with market trade.
DO NOT TRADE ANY STOCK WITHOUT LEVEL 2 STOCK QUOTES! QuoteDaddy.com delivers it's user with the most in-depth Level 2 Quotation System available on the Planet! NO Downloads, NO Widgets, NO Plugins required! Stay on TOP of your trades with QuoteDaddy.com! CLICK HERE TO START YOUR FREE 30-DAY TRIAL
